Vancouver-based Absci valued at nearly $2 billion in IPO trading
Vancouver-based biotechnology firm Absci went public on Thursday that resulted in a valuation of practically $ 2 billion. The information comes a bit of over a 12 months after the corporate first filed a registration assertion…